Literature DB >> 16378798

Cystatin-C and inflammatory markers in the ambulatory elderly.

Michael G Shlipak1, Ronit Katz, Mary Cushman, Mark J Sarnak, Catherine Stehman-Breen, Bruce M Psaty, David Siscovick, Russell P Tracy, Anne Newman, Linda Fried.   

Abstract

PURPOSE: Inflammatory factors are elevated in persons with severe renal dysfunction, but their association across all levels of renal function is unclear. We compared cystatin-C, a novel marker of renal function, with creatinine and estimated glomerular filtration rate (eGFR) as predictors of C-reactive protein and fibrinogen levels.
METHODS: This study is a cross-sectional analysis to evaluate cystatin-C, creatinine, and eGFR as predictors of the inflammatory markers C-reactive protein and fibrinogen. Participants included 4637 ambulatory elderly patients from the Cardiovascular Health Study. Multivariate linear regression was used to determine the independent associations of each renal function measurement with the inflammatory marker outcomes.
RESULTS: After adjustment for confounding factors, cystatin-C was correlated with both C-reactive protein (coefficient = 0.13; 95% confidence interval: 0.10-1.16, P <.0001) and fibrinogen levels (0.15; 0.13-0.18, P <.0001). Associations were larger than those for creatinine and C-reactive protein (0.05; 0.02-0.07, P = .003) or fibrinogen (0.07; 0.04-0.10, P <.0001). Adjusted levels of C-reactive protein increased incrementally across quintiles of cystatin-C, from a median of 2.2 mg/L in quintile 1 to 3.7 mg/L in quintile 5. In contrast, both C-reactive protein and fibrinogen had U-shaped associations with quintiles of creatinine and eGFR, because the inflammatory markers were equivalently elevated in quintiles 1 and 5.
CONCLUSIONS: The finding of a significant linear association of cystatin-C and inflammation markers suggests that even small reductions in renal function may be associated with adverse pathophysiologic consequences.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16378798     DOI: 10.1016/j.amjmed.2005.07.060

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  49 in total

Review 1.  Patterns of compensation and vulnerability in normal subjects at risk of Alzheimer's disease.

Authors:  Oscar L Lopez; James T Becker; Lewis H Kuller
Journal:  J Alzheimers Dis       Date:  2013       Impact factor: 4.472

2.  Cystatin C is associated with inflammation but not atherosclerosis in systemic lupus erythematosus.

Authors:  R Lertnawapan; A Bian; Y H Rho; P Raggi; A Oeser; J F Solus; T Gebretsadik; A Shintani; C M Stein
Journal:  Lupus       Date:  2011-11-09       Impact factor: 2.911

3.  Prevalence of CKD and comorbid illness in elderly patients in the United States: results from the Kidney Early Evaluation Program (KEEP).

Authors:  Lesley A Stevens; Suying Li; Changchun Wang; Cindy Huang; Bryan N Becker; Andrew S Bomback; Wendy Weinstock Brown; Nilka Ríos Burrows; Claudine T Jurkovitz; Samy I McFarlane; Keith C Norris; Michael Shlipak; Adam T Whaley-Connell; Shu-Cheng Chen; George L Bakris; Peter A McCullough
Journal:  Am J Kidney Dis       Date:  2010-03       Impact factor: 8.860

4.  Plasma Cystatin C Associates With HIV-Associated Neurocognitive Disorder but Is a Poor Diagnostic Marker in Antiretroviral Therapy-Treated Individuals.

Authors:  Robert C Kalayjian; Kevin R Robertson; Jeffrey M Albert; Carl J Fichtenbaum; Todd T Brown; Babafemi O Taiwo
Journal:  J Acquir Immune Defic Syndr       Date:  2019-06-01       Impact factor: 3.731

5.  GFR is better estimated by considering both serum cystatin C and creatinine levels.

Authors:  Yann Bouvet; François Bouissou; Yvon Coulais; Sophie Séronie-Vivien; Mathieu Tafani; Stéphane Decramer; Etienne Chatelut
Journal:  Pediatr Nephrol       Date:  2006-06-22       Impact factor: 3.714

Review 6.  Measuring glomerular filtration rate in children; can cystatin C replace established methods? A review.

Authors:  Trine Borup Andersen; Anni Eskild-Jensen; Jørgen Frøkiaer; Jens Brøchner-Mortensen
Journal:  Pediatr Nephrol       Date:  2008-10-07       Impact factor: 3.714

Review 7.  Statins, inflammation and kidney disease.

Authors:  Vera Krane; Christoph Wanner
Journal:  Nat Rev Nephrol       Date:  2011-05-31       Impact factor: 28.314

8.  Albuminuria, impaired kidney function and cardiovascular outcomes or mortality in the elderly.

Authors:  Dena E Rifkin; Ronit Katz; Michel Chonchol; Linda F Fried; Jie Cao; Ian H de Boer; David S Siscovick; Michael G Shlipak; Mark J Sarnak
Journal:  Nephrol Dial Transplant       Date:  2009-12-15       Impact factor: 5.992

9.  Association of visceral and subcutaneous adiposity with kidney function.

Authors:  Jill A Young; Shih-Jen Hwang; Mark J Sarnak; Udo Hoffmann; Joseph M Massaro; Daniel Levy; Emelia J Benjamin; Martin G Larson; Ramachandran S Vasan; Christopher J O'Donnell; Caroline S Fox
Journal:  Clin J Am Soc Nephrol       Date:  2008-09-24       Impact factor: 8.237

10.  Cystatin C and carotid intima-media thickness in asymptomatic adults: the Multi-Ethnic Study of Atherosclerosis (MESA).

Authors:  Anh L Bui; Ronit Katz; Bryan Kestenbaum; Ian H de Boer; Linda F Fried; Joseph F Polak; Bruce A Wasserman; Mark J Sarnak; David Siscovick; Michael G Shlipak
Journal:  Am J Kidney Dis       Date:  2008-09-27       Impact factor: 8.860

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.